Skip to main content
Dechra Pharmaceuticals PLC logo

Dechra Pharmaceuticals PLC — Investor Relations & Filings

Ticker · DPH ISIN · US2434351043 LEI · 213800J4UVB5OWG8VX82 IL Manufacturing
Open in API
Filings indexed 1,018 across all filing types
Latest filing 2019-06-30 Annual Report
Country GB United Kingdom
Listing IL DPH

About Dechra Pharmaceuticals PLC

https://www.dechra.com/

Dechra Pharmaceuticals PLC is a global specialist business focused on veterinary pharmaceuticals and related products. The company's expertise encompasses the development, manufacture, marketing, and sale of high-quality veterinary medicines. Its product portfolio includes both novel and differentiated generic pharmaceuticals, with a significant focus on products for companion animals. Dechra provides solutions and support to veterinary professionals worldwide to improve animal health and welfare.

Recent filings

Filing Released Lang Actions
Availability of the 2019 Annual Report
Annual Report Classification · 100% confidence The document is explicitly titled 'Annual Report and Accounts for the year ended 30 June 2019'. It contains comprehensive sections including a Strategic Report, Governance, Financial Statements (Income Statement, Balance Sheet, Cash Flows), and an Independent Auditors' Report. It is a full-length annual report, not an announcement or summary, and fits the definition of a 10-K (Annual Report). FY 2019
2019-06-30 English
Notice of Meeting - 2019 AGM
AGM Information Classification · 100% confidence The document is explicitly titled "ANNUAL GENERAL MEETING 2019 CHAIRMAN'S LETTER AND NOTICE OF ANNUAL GENERAL MEETING". It details the resolutions to be voted upon at the upcoming AGM, including receiving the Annual Report, Directors' Remuneration Report, approving the final dividend, electing/re-electing directors, re-appointing the auditor, and seeking authority for allotment of equity securities and share purchases. This content is the core material sent to shareholders to inform them about and solicit their votes for the Annual General Meeting. This aligns perfectly with the definition of AGM Information (AGM-R). Although it mentions the Annual Report and Remuneration Report, the document itself is the notice and supporting material for the meeting, not the reports themselves.
2019-06-30 English
Total Voting Rights
Regulatory Filings Classification · 98% confidence The document is identified by the 'RNS Number' header and explicitly states it is provided by 'RNS, the news service of the London Stock Exchange'. The content details the 'Total Voting Rights' (102,651,602 shares) as of the announcement date (28 June 2019), referencing DTR 5.6.1R. This type of mandatory notification regarding the total number of shares with voting rights, used as a denominator for shareholder disclosure calculations, is a standard regulatory announcement. While it relates to share capital, it is not a formal share issue (SHA) or a transaction in own shares (POS), but rather a required market disclosure. Given the RNS source and the nature of the disclosure, the most appropriate classification is Regulatory Filings (RNS), as it is a general regulatory announcement that doesn't fit the more specific categories like DIV, SHA, or DIRS.
2019-06-28 English
Total Voting Rights
Regulatory Filings Classification · 98% confidence The document is explicitly labeled with an 'RNS Number' and states that the information is provided by 'RNS, the news service of the London Stock Exchange.' The content details the 'Total Voting Rights' as of the announcement date (31 May 2019), which is a mandatory notification under DTR 5.6.1R. This type of general regulatory announcement that doesn't fit a more specific category (like Director's Dealing or Major Shareholding Notification) is best classified as a general Regulatory Filing or RNS announcement. Since RNS is provided as a specific code for general regulatory announcements, I will use RNS.
2019-05-31 English
Holding(s) in Company
Major Shareholding Notification Classification · 98% confidence The document is explicitly labeled with 'RNS Number : 9462X' and contains the standard header 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership, which directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific content is a mandatory regulatory filing regarding share ownership thresholds, making MRQ the most precise classification over the general RNS fallback.
2019-05-02 English
Total Voting Rights
Regulatory Filings Classification · 98% confidence The document is explicitly labeled with an 'RNS Number' and states, 'RNS Number : 6131X' and 'This information is provided by RNS, the news service of the London Stock Exchange.' The content details the 'Total Voting Rights' (102,629,904 ordinary shares) as of the announcement date (30 April 2019), referencing DTR 5.6.1R. This type of mandatory notification regarding the total number of shares with voting rights is a standard regulatory announcement. While it relates to share capital, it is a specific notification rather than a general share issue (SHA) or a transaction in own shares (POS). Given the explicit RNS labeling and the nature of the disclosure (Total Voting Rights notification), the most appropriate classification is Regulatory Filings (RNS), which serves as the general category for such mandatory market disclosures not covered by more specific codes like DIV or DVA.
2019-04-30 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.